Ilene Wiggins

Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)

Craig W. Hendrix, Adriana Andrade, Namandjé N. Bumpus et al. · AIDS Research and Human Retroviruses · 2015 · 176 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

Nimalie D. Stone, Shelia B. Dunaway, Charles Flexner et al. · Antimicrobial Agents and Chemotherapy · 2007 · 124 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers

Kelly E. Dooley, Jeong-Gun Park, Susan Swindells et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 82 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART

Sharon A. Riddler, Lu Zheng, Christine M. Durand et al. · Open Forum Infectious Diseases · 2018 · 36 citations · Full text

Pharmacy, Immunology, Pharmacology +14

Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine

Kimberly Y. Smith, C. Tierney, Katie R. Mollan et al. · Clinical Infectious Diseases · 2013 · 33 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17